Company Search:
Advanced Search
Sponsored Links
Aclaris Therapeutics Inc Company Snapshot
Aclaris Therapeutics Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Aclaris Therapeutics Inc with three other companies in this sector in the United States: Dova Pharmaceuticals Inc (2018 sales of $10.36 million of which 100% was Pharmaceutical), Concert Pharmaceuticals Inc ($10.51 million of which 100% was Biopharmaceutical), and Nabriva Therapeutics Plc ($9.66 million of which 100% was Pharmaceutical).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Aclaris Therapeutics Inc
  Stock Performance Chart for Aclaris Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (2/14/2020): 1.35
(Figures in U.S. Dollars)
1 Week 5.5%   13 Weeks -26.6%  
4 Weeks -26.2%   52 Weeks -81.8%  
Aclaris Therapeutics Inc Key Data:
  Ticker: ACRS Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 10,091,000
(Year Ending Jan 2019).
Employees: 169
  Currency: U.S. Dollars Market Cap: 55,874,383
  Fiscal Yr Ends: December Shares Outstanding: 41,388,432
  Share Type: Common Closely Held Shares: 4,027,657
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.